Osnat Ashur-Fabian, PhD

Osnat Ashur-Fabian, PhD, of Meir Medical Center, recipient of an ICRF Project Grant, is studying drug resistance in ovarian carcinoma, a cancer that ranks fifth in incidence in women. In order to improve treatment outcomes, she believes that a deeper understanding of resistance mechanisms is urgently needed. An enzyme called DIO3 was shown to be involved in ovarian cancer growth. Dr. Ashur-Fabian aims to study the potential role played by this enzyme in ovarian cancer treatment resistance, as well as the impact of inhibiting this enzyme as a novel approach for sensitizing cells to drugs.

View Grant Recipient profile